X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19098) 19098
Magazine Article (35) 35
Book / eBook (13) 13
Book Chapter (13) 13
Dissertation (8) 8
Publication (7) 7
Web Resource (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18912) 18912
science & technology (14443) 14443
life sciences & biomedicine (14182) 14182
male (10954) 10954
female (10405) 10405
child (9363) 9363
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8185) 8185
adolescent (7540) 7540
hematology (7378) 7378
oncology (7309) 7309
child, preschool (6490) 6490
adult (5574) 5574
precursor cell lymphoblastic leukemia-lymphoma - therapy (4730) 4730
infant (3955) 3955
precursor cell lymphoblastic leukemia-lymphoma - genetics (3508) 3508
pediatrics (3412) 3412
antineoplastic combined chemotherapy protocols - therapeutic use (3363) 3363
middle aged (3307) 3307
leukemia (3228) 3228
precursor cell lymphoblastic leukemia-lymphoma - pathology (3090) 3090
acute lymphoblastic leukemia (2840) 2840
prognosis (2825) 2825
treatment outcome (2780) 2780
precursor cell lymphoblastic leukemia-lymphoma - complications (2401) 2401
cancer (2290) 2290
acute lymphocytic leukemia (2210) 2210
precursor cell lymphoblastic leukemia-lymphoma - mortality (2200) 2200
remission induction (2185) 2185
recurrence (1906) 1906
abridged index medicus (1835) 1835
risk factors (1826) 1826
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (1795) 1795
chemotherapy (1793) 1793
aged (1756) 1756
retrospective studies (1600) 1600
children (1585) 1585
young adult (1559) 1559
antineoplastic agents - therapeutic use (1517) 1517
follow-up studies (1355) 1355
transplantation (1354) 1354
care and treatment (1346) 1346
disease-free survival (1346) 1346
animals (1342) 1342
research (1323) 1323
precursor cell lymphoblastic leukemia-lymphoma - metabolism (1229) 1229
combined modality therapy (1225) 1225
survival rate (1197) 1197
precursor cell lymphoblastic leukemia-lymphoma - immunology (1177) 1177
antineoplastic combined chemotherapy protocols - adverse effects (1169) 1169
acute lymphatic leukemia (1162) 1162
bone marrow transplantation (1118) 1118
health aspects (1114) 1114
transplantation, homologous (1055) 1055
precursor cell lymphoblastic leukemia-lymphoma - blood (1000) 1000
hematopoietic stem cell transplantation (991) 991
immunology (983) 983
time factors (977) 977
analysis (976) 976
genetic aspects (965) 965
methotrexate - administration & dosage (963) 963
cell line, tumor (930) 930
survival analysis (911) 911
mice (883) 883
antineoplastic agents - adverse effects (815) 815
acute disease (809) 809
immunophenotyping (803) 803
leukemia, myeloid, acute - therapy (777) 777
medicine & public health (764) 764
leukemia, myeloid, acute - drug therapy (763) 763
lymphatic leukemia (758) 758
vincristine - administration & dosage (751) 751
stem cells (741) 741
flow cytometry (726) 726
precursor cell lymphoblastic leukemia-lymphoma - radiotherapy (721) 721
hematology, oncology and palliative medicine (716) 716
hemic and lymphatic diseases (710) 710
philadelphia chromosome (694) 694
all (686) 686
bone marrow (677) 677
prospective studies (674) 674
antineoplastic combined chemotherapy protocols - administration & dosage (661) 661
apoptosis (643) 643
gene expression (639) 639
asparaginase - administration & dosage (636) 636
general & internal medicine (634) 634
mutation (634) 634
cytarabine - administration & dosage (627) 627
pharmacology & pharmacy (620) 620
medicine, general & internal (618) 618
antineoplastic agents - pharmacology (606) 606
hematopoietic stem cells (603) 603
age factors (601) 601
infant, newborn (598) 598
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (582) 582
precursor cell lymphoblastic leukemia-lymphoma - epidemiology (578) 578
diagnosis (571) 571
t cells (567) 567
bone marrow - pathology (563) 563
methotrexate - adverse effects (562) 562
translocation, genetic (553) 553
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17906) 17906
Chinese (415) 415
Japanese (382) 382
Spanish (204) 204
German (193) 193
French (180) 180
Polish (170) 170
Russian (121) 121
Portuguese (45) 45
Italian (40) 40
Czech (21) 21
Danish (21) 21
Dutch (19) 19
Hungarian (18) 18
Norwegian (13) 13
Serbian (11) 11
Croatian (7) 7
Finnish (7) 7
Romanian (6) 6
Turkish (6) 6
Hebrew (5) 5
Korean (5) 5
Swedish (4) 4
Bosnian (3) 3
Slovak (3) 3
Ukrainian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica (Roma), ISSN 1592-8721, 05/2007, Volume 92, Issue 5, pp. 612 - 618
...{at}ospedaliriuniti.bergamo.it Background and Objectives: The molecular analysis of minimal residual disease (MRD) may provide informaton on the risk of recurrence in patients with acute lymphoblastic leukemia... 
ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
American journal of clinical pathology, ISSN 1943-7722, 09/2015, Volume 144, Issue 3, pp. 411 - 422
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Journal Article
Blood, ISSN 1528-0020, 08/2011, Volume 118, Issue 8, pp. 2077 - 2084
Journal Article
Leukemia & lymphoma, ISSN 1029-2403, 02/2011, Volume 52, Issue 6, pp. 1098 - 1107
Monoclonal antibody (MoAb)-based therapies have opened innovative treatment avenues that have impacted on the management of patients with both neoplastic and non-neoplastic hematological diseases... 
mean fluorescence intensity (MFI) | monoclonal antibody therapy | antigen expression | antibody binding capacity (ABC) | Acute lymphoid leukemia (ALL) | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Middle Aged | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Sialic Acid Binding Ig-like Lectin 2 - immunology | Antigens, CD - metabolism | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Aged, 80 and over | Adult | Transcription, Genetic | Sialic Acid Binding Ig-like Lectin 3 | Child | Antibodies, Monoclonal - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antigens, CD19 - immunology | Antigens, CD20 - immunology | Immunophenotyping | Antigens, CD20 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Reverse Transcriptase Polymerase Chain Reaction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Antigens, CD19 - metabolism | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
BACKGROUND Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is characterized by a gene-expression profile similar to that of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Adolescents | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Index Medicus | Abridged Index Medicus
Journal Article